The U.S. Agency for International Development (USAID) has released a new report to Congress, “Health-Related Research and Development Activities at USAID” – the final annual update on the results of the USAID 2006-10 health research strategy.
The report is being released in sections over a five-week period, and the HIV/AIDS chapter is now available for download. The chapter discusses advances made in microbicides, vaccine development, and applied research and public health evaluation. The chart to the right shows the funding each of these areas received in fiscal year (FY) 2010.
“USAID’s bold investment in a South African research team, with the help of 889 female volunteers in Durban, South Africa, showed for the first time that an antiretroviral microbicide gel can reduce the risk of HIV infection in women effectively by half,” a USAID press release stated. “The results of the CAPRISA trial are a watershed moment in empowering women in the fight against HIV/AIDS.”